{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fmycme.simplecast.com%2Fepisodes%2Fnsaid-allergy-diagnosis-and-management-oYCfw_9r","width":444,"version":"1.0","type":"rich","title":"NSAID Allergy: Diagnosis and Management","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/e71aa0ce-5e2e-47d7-9bf5-f7e1653c93ab/23527d63-940d-4dc3-967c-84d50e21ad11/cme-square.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"","height":200,"description":"Important: After listening to the podcast, you will need to visit myCME to complete the post-assessment and evaluation and to claim your credits and certificate for this activity. Please go to www.mycme.com/allergy1 on any browser to complete the activity.\n\n\nHypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) are some of the most common drug reactions encountered in clinical practice. This program presents a practical approach to the evaluation and treatment of patients with NSAID allergies.\n\nThis activity is designed for Allergists/Immunologists, as well as internists and primary care clinicians.\n\nThis activity is not commercially supported.\n\nAt the conclusion of this activity, participants should be better able to:\n\nRecognize and differentiate between the four common types of acute NSAID-induced reactions\nDescribe the diagnostic evaluation for NSAID-induced reactions\nAssess the safety of selective COX-2 inhibitors in patients reporting NSAID allergy\nDiscuss the role, safety, and efficacy of aspirin desensitization in patients with significant underlying pulmonary and cardiovascular disease\nExplain the current understanding of the mechanisms of NSAID-induced reactions\nSpeaker\n\nKatherine Cahill, MD\nAssistant Professor of Medicine\nMedical Director of Clinical Asthma Research\nVanderbilt University Medical Center.\nNashville, TN\n\nDr. Cahill serves as an advisor for AstraZeneca, Blueprint Medicines Corporation, Genentech, a member of the Roche Group, GlaxoSmithKline Pharmaceuticals Ltd, Novartis Pharmaceuticals Corp., and Sanofi. She is also a consultant for Ribon Therapeutics, Inc., Third Harmonic Bio, Inc., and Verantos, Inc.\n\nAll of the relevant financial relationships listed for this individual have been mitigated."}